Capula Management LTD Insulet Corp Transaction History

Capula Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $17,166 - $20,804	63 Added 7.35%	920 $265,000
Q1 2023 May 10, 2023	BUY	$276.36 - $326.03 $236,840 - $279,407	857 New	857 $273,000
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $368,171 - $458,974	-1,442 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$260.36 - $307.27 $159,861 - $188,663	614 Added 74.15%	1,442 $410,000
Q2 2021 Aug 13, 2021	BUY	$225.52 - $304.06 $186,730 - $251,761	828 New	828 $227,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.